The Single Use Bioprocessing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of single-use bioprocessing has seen a quick expansion in the recent past. It is projected to increase from $26.87 billion in 2024 to $32.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 19.2%. The historical growth trend in the Single Use Bioprocessing Global Market Report 2025 illustrates significant expansion.
The Single Use Bioprocessing Global Market is projected to grow to $68.6 billion in 2029, with a compound annual growth rate (CAGR) of 21.0%.
Download Your Free Sample of the 2025 Single Use Bioprocessing Market Report and Uncover Key Trends Now!The key drivers in the single use bioprocessing market are:
• Expansion of personalized medicine, gene and cell therapy production
• Increased adoption of continuous bioprocessing
• Biomanufacturing aimed at addressing rare diseases
• Growth of biosafety levels, emerging markets, and global biomanufacturing hubs
The single use bioprocessing market covered in this report is segmented –
1) By Product: Single-Use Media Bags And Containers, Single-Use Assemblies, Single-Use Bioreactors, Disposable Mixers, Other Products
2) By Workflow: Upstream, Fermentation, Downstream
3) By Application: Filtration, Storage, Cell Culture, Mixing, Purification
4) By End User: Biopharmaceutical And Pharmaceutical companies, Contract Research Organizations And Contract Manufacturing Organizations (CROs and CMOs), Academic and Research institutes
The key trends in the integrated passive devices market are:
• Automated and robotic single-use systems are an emerging trend.
• Single-use sensors and analytics are shaping the future market.
• A trend toward closed-system aseptic filling and packaging is expected.
• There is an increasing shift towards modular and scalable bioprocessing facilities, on-demand and decentralized biomanufacturing.
Major companies in the single use bioprocessing market are:
• GE Healthcare Technologies Ltd.
• Eppendorf AG
• Corning Incorporated
• Thermo Fisher Scientific Inc.
• Sartorius AG
• JM BioConnect BV
• Merck KGaA
• Pall Corporation
• Kuhner AG
• PBS Biotech Inc.
• Entegris Inc.
• DistriCell Inc.
• ABEC Inc.
• Able Corporation and Biott Corporation
• Solida Biotech GmbH
• OmniBRx Biotechnologies Pvt. Ltd.
• Satake Chemical Equipment Mfg. Co. Ltd.
• Stobbe Pharma GmbH
• Celltainer Biotech BV
• Cellexus BV
• Danaher Corporation
• Boehringer Ingelheim International GmbH
• General Electric Company
• Rentschler Biopharma SE
• Repligen Corporation
• Sollesis Medical Plc
• Charter Medical Inc.
• Secant Group LLC
• Lonza Group Ltd.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Pfizer Inc.
• Catalent Inc.
• Patheon Inc.
• Avantor Performance Materials India Limited
• MilliporeSigma
• Meissner Filtration Products Inc.
North America was the largest region in the single-use bioprocessing market in 2024